Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study - 05/03/16
, Emilie Acquacalda b, Frédéric Berthier c, Christine Albert b, Gilles Bolla d, Elodie Millasseau e, Claire Destombe e, Johanna Azulay d, Caroline Asquier d, Amélie Florent b, Sylvie Le Seaux e, Liana Euller-Ziegler bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objectives |
To evaluate influenza and pneumococcal vaccine coverage in patients taking biological therapy for chronic inflammatory joint disease and to identify factors associated with the decision to administer these two vaccines.
Methods |
Retrospective cross-sectional questionnaire study of a cohort of 584 patients taking biological therapy for chronic inflammatory joint disease (rheumatoid arthritis or spondyloarthritis). We studied the influenza and pneumococcal vaccine coverage rates, information about these vaccines given to patients by the primary-care physician and rheumatologist, and reasons for not administering the vaccines.
Results |
Overall vaccine coverage rates were 44% for influenza and 62% for pneumococcus. Factors associated with being vaccinated were patient age, previous influenza vaccination, and patient information. Concern about adverse effects and absence of patient information by the primary-care physician and rheumatologist were associated with very low coverage rates.
Conclusion |
This study showed insufficient vaccine coverage rates, particularly against influenza, in a population at high risk because of exposure to biological therapy. Patient information by healthcare professionals about influenza and pneumococcal vaccination has a major impact and should be renewed as often as possible.
Le texte complet de cet article est disponible en PDF.Keywords : Influenza vaccination, Pneumococcal vaccination, Biological therapy, Chronic inflammatory joint disease
Plan
Vol 83 - N° 2
P. 155-159 - mars 2016 Retour au numéro
Article précédent
- Usefulness of intra-articular botulinum toxin injections. A systematic review
- Hichem Khenioui, Eric Houvenagel, Jean François Catanzariti, Marc Alexandre Guyot, Olivier Agnani, Cécile Donze
- Short-term efficacy to conventional blind injection versus ultrasound-guided injection of local corticosteroids in tenosynovitis in patients with inflammatory chronic arthritis: A randomized comparative study
- Marwin Gutierrez, Andrea Di Matteo, Marcos Rosemffet, Tomas Cazenave, Gustavo Rodriguez-Gil, Cristina Hernandez Diaz, Lucio Ventura Rios, Natalia Zamora, Maria del Carmen Gonzalez Guzman, Ignacio Carrillo, Tadashi Okano, Fausto Salaffi, Carlos Pineda, Pan-American League against Rheumatisms (PANLAR) Ultrasound Study Group 1
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?